Clinically Meaningful And Long-Term Improvements In Fatigue With The C3 Inhibitor Pegcetacoplan In Paroxysmal Nocturnal Hemoglobinuria: Post-Hoc Analyses From The PEGASUS Study Week 48 (ISTH 2021) - Apellis Medical Hub

Clinically Meaningful And Long-Term Improvements In Fatigue With The C3 Inhibitor Pegcetacoplan In Paroxysmal Nocturnal Hemoglobinuria: Post-Hoc Analyses From The PEGASUS Study Week 48

Share Via Email

Back to Conference Resources

PNH Congress Presentations International Society on Thrombosis and Haemostasis (ISTH) 2021

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.